CYCLERION THERAPEUTICS, INC.

Company

Cyclerion Therapeutics, Inc.

Filed

August 10, 2020

Accession Number

0000902664-20-002944

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →